Literature DB >> 10965621

Clinical experience of milrinone as a pharmacological bridge to heart transplantation.

T Koyanagi1, S Kyo, H Ouchi, H Asano, Y Yokote, R Omoto.   

Abstract

A 19-year-old man with idiopathic dilated cardiomyopathy developed cardiogenic shock. A HeartMate left ventricular assist device was inserted as an emergency procedure, but removed after 189 days due to sepsis related to the device. Intravenous milrinone was administered because of recurrence of heart failure, and as a result the symptoms disappeared and the urinary output increased. Echocardiography showed improvement in the left ventricular ejection fraction. Subsequently, the patient successfully underwent heart transplantation. Milrinone was effective as a pharmacological bridge to heart transplantation in this patient with terminal and critical heart failure after removal of a left ventricular assist device.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10965621     DOI： 10.1007/bf03218176

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN： 1344-4964


  9 in total

1.  Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation.

Authors:  J R Skoyles; K M Sherry; C Price
Journal:  J Cardiothorac Vasc Anesth       Date:  1992-04       Impact factor: 2.628

2.  Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.

Authors:  R P Karlsberg; M A DeWood; A N DeMaria; M R Berk; K P Lasher
Journal:  Clin Cardiol       Date:  1996-01       Impact factor: 2.882

3.  Short-term use of intravenous milrinone for heart failure.

Authors:  M A Konstam; R J Cody
Journal:  Am J Cardiol       Date:  1995-04-15       Impact factor: 2.778

4.  Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy.

Authors:  S J Brecker; H B Xiao; M Mbaissouroum; D G Gibson
Journal:  Am J Cardiol       Date:  1993-01-15       Impact factor: 2.778

5.  Cardiac allograft failure: successful use of biventricular assist device.

Authors:  J Jaggers; D A Fullerton; D N Campbell; B Andrea; S D Jones; J M Brown; E E Wolfel; J Lindenfeld; F L Grover; M R Bristow
Journal:  Ann Thorac Surg       Date:  1995-11       Impact factor: 4.330

6.  A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction.

Authors:  E B Lobato; O Florete; H L Bingham
Journal:  Br J Anaesth       Date:  1998-11       Impact factor: 9.166

7.  [Additive effects of milrinone and dobutamine in severe heart failure].

Authors:  A Meissner; G Herrmann; L Gerdesmeyer; R Simon
Journal:  Z Kardiol       Date:  1992-05

8.  Milrinone, a bridge to heart transplantation.

Authors:  D M Watson; K M Sherry; G A Weston
Journal:  Anaesthesia       Date:  1991-04       Impact factor: 6.955

Review 9.  Use of milrinone in cardiac surgical patients.

Authors:  K M Sherry; T J Locke
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727
  9 in total
  2 in total

Review 1.  Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

Authors:  Yuan James Rao; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

Review 2.  Perioperative pharmacotherapy in patients with left ventricular assist devices.

Authors:  Nicholas C Dang; Yoshifumi Naka
Journal:  Drugs Aging       Date:  2004       Impact factor: 4.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.